BA
BLFS icon

Bridgewater Associates’s BioLife Solutions BLFS Stock Holding History

Bridgewater Associates’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-62,642
Closed -$1.43M – 834
2022
Q3 		$1.43M Buy
62,642
+287
+0.5% +$6.14K 0.01% 628
2022
Q2 		$861K Buy
62,355
+6,325
+11% +$92.8K ﹤0.01% 810
2022
Q1 		$1.27M Buy
56,030
+13,058
+30% +$344K 0.01% 771
2021
Q4 		$1.6M Buy
42,972
+3,448
+9% +$148K 0.01% 493
2021
Q3 		$1.67M Sell
39,524
-2,496
-6% -$120K 0.01% 457
2021
Q2 		$1.87M Buy
+42,020
New +$1.48M 0.01% 500

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Bridgewater Associates's BLFS Position: Q4 2022 in Review

Bridgewater Associates sold out of BioLife Solutions (BLFS) in Q4 2022, closing a stake of 62,642 shares — an estimated $1.43M sold.

Bridgewater Associates first reported a position in BLFS in Q2 2021 and held it in 6 quarters. The position peaked at $1.87M in Q2 2021. 165 funds tracked by Wall St. Rank hold BLFS as of Q4 2022.

  • Bridgewater Associates reported no remaining BioLife Solutions position as of Q4 2022 after selling out during the quarter.
  • Bridgewater Associates sold 62,642 BioLife Solutions shares in Q4 2022, an estimated $1.43M.
  • Bridgewater Associates first reported a position in BioLife Solutions in Q2 2021 and held it in 6 quarters.
  • Bridgewater Associates's BioLife Solutions position peaked at $1.87M in Q2 2021.
  • 165 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2022.

Based on Bridgewater Associates's 13F filing for Q4 2022, filed 13 Feb 2023.